Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia

Blood. 2003 Jan 1;101(1):375-6. doi: 10.1182/blood-2002-08-2557.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzamides
  • Biomarkers
  • Granulocytes / ultrastructure*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Telomere / metabolism
  • Telomere / ultrastructure*
  • Treatment Outcome

Substances

  • Benzamides
  • Biomarkers
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate